Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-07

Clinical Trial Update: Mechanisms of Semaglutide Therapy in Heart Failure Patients [Phase 1, Phase 2]

View source ↗

Summary

A multi-phase clinical trial is investigating how semaglutide works in patients with heart failure and obesity. It is currently recruiting for Phase 1/2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • semaglutide (semaglutide)

Snippet

Sponsor: University Medical Centre Ljubljana | Conditions: Heart Failure, Obesity | Phase 1, Phase 2 | Status: RECRUITING